Detalhe da pesquisa
1.
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Am Heart J
; 231: 128-136, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045224
2.
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: rationale and design of the RIVER trial
Am. heart j
; (231): 128-136, Jan. 2021. tab.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1145450